Health / epinephrine In Surprise Move, FDA Rejects Needle-Free EpiPen Rival It wants ARS Pharmaceuticals to conduct additional research on its Neffy nasal spray By Kate Seamons Posted Sep 20, 2023 9:13 AM CDT Copied Back